Back to School: How biopharma can reboot drug development. Access exclusive analysis here

H7N1 vaccine: Phase I data

In a Norwegian Phase I trial in 60

Read the full 81 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE